All Stories

  1. Climate change as a modifier of paediatric lung-function trajectories
  2. Seasonal Changes in Circulating Alpha-1 Antitrypsin Are Altered by Sex and Genetic Deficiency
  3. An update on targeting airway inflammation in cystic fibrosis
  4. Citrullination, a novel posttranslational modification of elastin, is involved in COPD pathogenesis
  5. Neutrophil-Derived Peptidyl Arginine Deiminase Activity Contributes to Pulmonary Emphysema by Enhancing Elastin Degradation
  6. Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin Deficiency
  7. Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline—A Multinational Registry Analysis
  8. Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis
  9. Alpha-1 antitrypsin deficiency: current therapy and emerging targets
  10. A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19
  11. Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications
  12. Attitudes Towards Vaccination for Coronavirus Disease 2019 in Patients with Severe Alpha-1 Antitrypsin Deficiency
  13. C3d Elicits Neutrophil Degranulation and Decreases Endothelial Cell Migration, with Implications for Patients with Alpha-1 Antitrypsin Deficiency
  14. In vitro and in vivo modulation of NADPH oxidase activity and reactive oxygen species production in human neutrophils by α1-antitrypsin
  15. Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals
  16. Altered Degranulation and pH of Neutrophil Phagosomes Impacts Antimicrobial Efficiency in Cystic Fibrosis
  17. Characterization of the Inflammatory Response to Severe COVID-19 Illness
  18. Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis
  19. Clinical presentation and immune characteristics in first-lactation Holstein-Friesian cows following intramammary infection with genotypically distinct Staphylococcus aureus strains
  20. α1 Antitrypsin therapy modulates the neutrophil membrane proteome and secretome
  21. Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency
  22. Anti-cytokines as a Strategy in Alpha-1 Antitrypsin Deficiency
  23. Targeting airway inflammation in cystic fibrosis
  24. The in vitro host cell immune response to bovine-adapted Staphylococcus aureus varies according to bacterial lineage
  25. EHS matrix incubated in media containing penicillin retains sufficient concentrations of antibiotic to inhibit growth of susceptible microorganisms
  26. Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its Symptoms
  27. Residence in biofilms allows Burkholderia cepacia complex (Bcc) bacteria to evade the anti-microbial activities of neutrophil-like dHL60 cells
  28. Mcl-1 is vital for neutrophil survival
  29. Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: A systematic review